Clinical trials
HPV clinical trials
Below are recruiting hpv clinical trials, each written for real people, not researchers. We’re tracking 257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06640283RecruitingPhase 2
Circulating tumor DNA monitoring for cervical and anal cancer
This trial uses a blood test to track tumor DNA in patients with HPV-related cervical or anal cancer. It aims to see if this test can detect early signs of recurrence after radiation therapy, helping guide follow-up care.
São PauloAges 18 years+ - NCT06686043RecruitingPhase 2
HPV vaccine, imiquimod, and metformin for advanced cervical or vulvar cancer
This trial tests a combination of an HPV vaccine, an immune cream (imiquimod), and a diabetes drug (metformin) together with standard chemoradiation. The goal is to see if this mix helps treat advanced cervical, vaginal, or vulvar cancers better than standard care alone.
Houston, TexasAges 18–64 - NCT06815939Recruiting
A Simple, Lab-Free Test for Cervical Cancer
This trial is testing a new, low-cost, lab-free screening test for cervical cancer. The goal is to see if it can detect early signs of cancer without needing a doctor's visit or a lab — making it easier for women to get screened.
San SalvadorAges 30–59 - NCT06862102Recruiting
Multiple HPV Infections and Cervical Lesion Risk
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
Pavia, PaviaAges 18 years+ - NCT06914999RecruitingEarly Phase 1
Comparing a new scan to standard scan during head and neck cancer radiation
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Atlanta, GeorgiaAges 18 years+ - NCT07087145Recruiting
HPV test by mail for men with HIV
This trial explores if mailing an HPV self-test kit to your home is a good way to screen for HPV. It's for men over 35 who have sex with men, including trans women, and are living with HIV.
San Francisco, CaliforniaAges 35 years+ - NCT07301905Recruiting
HPV vaccine study for parents in Flint, MI
This study tests a culturally tailored health message to see if it helps parents feel more open to the HPV vaccine for their daughters. It focuses on families in Flint whose daughters have not yet received the vaccine.
Flint, MichiganAges 18 years+ - NCT07345897Recruiting
Cervical cancer screening via self-sampling in the ER
This trial lets you collect your own cervical sample in the emergency department to check for cancer-causing HPV. It aims to make screening easier for people who might not get tested otherwise.
Rochester, New YorkAges 30–65 - NCT07414719Recruiting
HPV vaccine study for teens and teachers in AuRA
This study tests a program to increase HPV vaccination among teens aged 11-17 in public schools. It aims to see if education and support can help more adolescents get the vaccine to prevent HPV-related cancers.
Saint-PriestAges 11–17 - NCT07572396RecruitingPhase 2
HPV treatment with vaginal suppositories for mild cervical changes
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
Shatin, New TerritoriesAges 18–65 - NCT06942286Enrolling by invitation
HPV self-testing for cervical cancer screening in Indonesia
This study tests a home-based HPV self-collection kit for women who haven't been screened recently. The goal is to find cervical pre-cancer early, so treatment can prevent cancer.
Lebak, BantenAges 30–69 - NCT06144229Enrolling by invitation
HPV Vaccine in Women with HIV
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
Denver, ColoradoAges 21–40 - NCT07195734RecruitingPhase 2
Adding chemo or immunotherapy before surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy or chemotherapy plus immunotherapy before surgery can improve outcomes for people with advanced head and neck cancer that has come back or not gone away after prior treatment.
Tucson, ArizonaAges 18 years+ - NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Phoenix, ArizonaAges 18 years+ - NCT06915038Recruiting
Measuring tumor DNA in blood for HPV-positive throat cancer
This study looks at a blood test that finds DNA from HPV-related throat tumors. It may help doctors decide on surgery and check if the cancer is completely removed.
Carmel, IndianaAges 18 years+ - NCT07758140Recruiting
At-home cervical cancer screening study
This study tests if women can collect their own samples at home to screen for cervical cancer, which could make screening easier and more comfortable. You would provide a sample and compare it to a standard doctor-collected sample.
Phoenix, ArizonaAges 25–65 - NCT07336134Recruiting
HPV self-test for cervical health
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
Philadelphia, PennsylvaniaAges 25–65 - NCT06414057Recruiting
HPV study for women at higher risk in Scotland
This study looks at ways to improve cervical cancer prevention for women in Scotland who face extra challenges, such as addiction, homelessness, prison, or sex work. It includes a vaccination and screening part, plus an interview to hear your views.
EdinburghAges 25–45 - NCT06671210Recruiting
Urine HPV testing for men
This study is testing whether a urine test can detect human papillomavirus (HPV) in men. HPV is a common virus that can cause certain cancers. The goal is to see if a simple urine test works as well as other methods. If you are an adult male who has been sexually active, this study may be an option.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04611022Recruiting
Help increase HPV vaccine completion in Denver families
This study tests an educational program to help people in Denver who have not yet started the HPV vaccine (or haven’t finished it) complete the vaccine series. It may help families understand the vaccine and follow through with completing the recommended doses.
Denver, ColoradoAges 18 years+ - NCT04966481RecruitingPhase 3
Palbociclib plus cetuximab versus cetuximab alone
This trial studies whether adding palbociclib to cetuximab works better than cetuximab by itself for head and neck cancer that is growing again after an anti–PD-1/PD-L1 treatment. It is for people whose tumor has a specific gene change (CDKN2A loss) and who have not had too many prior treatments.
Worthington, MinnesotaAges 18 years+ - NCT07407569RecruitingPhase 2
HPV vaccine study for women with HPV16
This study tests how HPV antibodies work in urine samples from women with HPV16 before and after they get the HPV vaccine (Gardasil 9). It helps researchers understand how the vaccine protects against HPV.
Antwerp, WilrijkAges 18–45 - NCT07493824RecruitingPhase 4
Study of Paiteling Antibacterial Liquid for Persistent HPV Infection
This trial tests an antibacterial liquid (Paiteling®) to see if it can clear a persistent high-risk HPV infection of the cervix. It may be an option for women whose HPV has lasted 2 years or more and whose cervical biopsy shows only mild changes.
Changchun, JilinAges 26–65 - NCT05208710RecruitingEarly Phase 1
Study new HPV vaccine in healthy adults
This early study tests a new HPV (human papillomavirus) vaccine to see if it can safely trigger an immune response in healthy adults. It’s for people who have not had an HPV vaccine before and can follow study vaccination and pregnancy-prevention rules.
HeidelbergAges 18–45
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hpv?
- Yes. Clin2 currently lists 257 recruiting hpv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hpv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hpv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.